Rani raises $53M series D round

Rani Therapeutics LLC (San Jose, Calif.) raised $53 million in a series D round. New investors GeneScience Pharmaceuticals Co. Ltd. (Changchun, China), Shire plc (LSE:SHP; NASDAQ:SHPG), Bossa Ventures and Cathay Venture participated, as did existing investors GV, Novartis AG (NYSE:NVS; SIX:NOVN), AstraZeneca plc (LSE:AZN; NYSE:AZN), Ping An Ventures and Virtus Ventures. ...